The predictive value of wheat specific immunoglobulin E levels in serum for the outcome of wheat-specific oral immunotherapy

The predictive value of wheat specific immunoglobulin E levels in serum for the outcome of wheat-specific oral immunotherapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210524004

Enrollment

Registered

2021-05-24

Start date

2020-10-30

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Little is known about the factors associate with the worse outcome of wheat OIT in patients with an IgE-mediated wheat allergy. wheat oral immunotherapy

Interventions

Difficult case was defined as at least one of what we described below. I. During the build-up phase at the hospital and/or home a. Patients who experienced at least grade 2 severity of reaction (WAO)

Treatment,Treatment

difficult case,usual case

Eligibility

Sex/Gender

All

Age

1 Days to 18 Years

Inclusion criteria

Inclusion criteria: Children under 18 years with a history of IgE-mediated wheat allergy who had positive results in an oral food challenge (OFC) and underwent wheat OIT between 2012 and 2020 at Siriraj hospital and Samitivej Thonburi Institute (SAI), Bangkok, Thailand.

Exclusion criteria

Exclusion criteria: the patients who had incomplete medical records

Design outcomes

Primary

Measure	Time frame
Wheat-specific IgE Baseline Immunocap testing	—

Secondary

Measure	Time frame
Other characteristics baseline and follow until the date of study medical record	—

Countries

Thailand

Contacts

Public ContactSiriluck Witeetanavanich

Siriraj hospital

dreamypui@gmail.com66870810120

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026